Back to HSGX Stock Lookup

Histogenics (HSGX) – Business Wire

Sep 30, 2019 07:30 AM Ocugen Announces Completion of its Merger with Histogenics to Create Nasdaq-Listed Clinical-Stage Company Developing Novel Ocular Gene Therapies and Biotherapeutics

Back to HSGX Stock Lookup